Loading chat...

NJ A2587

Bill

Status

Introduced

1/9/2024

Primary Sponsor

Jessica Ramirez

Click for details

Origin

General Assembly

2024-2025 Regular Session

AI Summary

  • Prohibits drug manufacturers, pharmacies, wholesalers, and medication supply intermediaries from entering agreements with healthcare practitioners to dispense drugs via devices or kiosks that steer patients to specific pharmacies or restrict pharmacy choice

  • Requires practitioners using prescription dispensing devices to either obtain voluntary patient consent for transmitting information to a specific pharmacy, or provide full disclosure of the transmission with notice of the patient's right to choose their own pharmacy

  • Establishes civil penalties for steering violations: minimum $100,000 for first offense, $200,000 for second, and $400,000 for subsequent violations by manufacturers/pharmacies; $250-$1,000 escalating penalties for practitioners

  • Prohibits prescription dispensing devices from using patient medical information for marketing or selling it to promote specific pharmacies or medications without HIPAA-compliant authorization under 45 C.F.R. s.164.508

  • Requires dispensing devices to notify patients of any insurance charges related to transmitting their medical information and any benefits they may receive from using the system

Legislative Description

Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.

Health

Last Action

Introduced, Referred to Assembly Health Committee

1/9/2024

Committee Referrals

Health1/9/2024

Full Bill Text

No bill text available